Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer

Alessandra Fabi; Luisa Carbognin; Andrea Botticelli; Ida Paris; Paola Fuso; Maria Cristina Savastano; Nicla La Verde; Carla Strina; Rebecca Pedersini; Stefania Guarino; Giuseppe Curigliano; Carmen Criscitiello; Mimma Raffaele; Alessandra Beano; Antonio Franco; Maria Rosaria Valerio; Francesco Verderame; Andrea Fontana; Eva Regina Haspinger; Alessia Caldara; Alba Di Leone; Giampaolo Tortora; Diana Giannarelli; Giovanni Scambia

doi:10.1038/s41523-024-00619-5

Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer

Alessandra Fabi
, Luisa Carbognin
, Andrea Botticelli
, Ida Paris
, Paola Fuso
, Maria Cristina Savastano
, Nicla La Verde
, Carla Strina
, Rebecca Pedersini
, Stefania Guarino
, Giuseppe Curigliano
, Carmen Criscitiello
, Mimma Raffaele
, Alessandra Beano
, Antonio Franco
, Maria Rosaria Valerio
, Francesco Verderame
, Andrea Fontana
, Eva Regina Haspinger
, Alessia Caldara

Alba Di Leone, Giampaolo Tortora, Diana Giannarelli, Giovanni Scambia

Merano Hospital

Precision Medicine Unit in Senology
Division of Gynecology Oncology
Medical Oncology Unit
Medical Oncology Unit Azienda Socio-Sanitaria Territoriale Cremona
Medical Oncology Unit ASST Spedali Civili
Medical Oncology Unit Santa Maria della Misericordia Hospital
University of Milan-Bicocca
Presidio Cassia Sant'andrea
A.O.U. Città della Salute e della Scienza-Regina Margherita Children Hospital
Breast Unit
University of Pisa and Azienda Ospedaliero Universitaria Pisana
Azienda Sanitaria dell'Alto Adige - Ospedale di Merano
Santa Chiara Hospital
Epidemiology and Biostatistics Facility

Research output: Contribution to journal › Correction › peer-review

Original language	English
Pages (from-to)	13
Journal	NPJ breast cancer
Volume	10
Issue number	1
DOIs	https://doi.org/10.1038/s41523-024-00619-5
Publication status	Published - 5 Feb 2024

Access to Document

10.1038/s41523-024-00619-5

1 Original Article

Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer
Fabi, A., Carbognin, L., Botticelli, A., Paris, I., Fuso, P., Savastano, M. C., La Verde, N., Strina, C., Pedersini, R., Guarino, S., Curigliano, G., Criscitiello, C., Raffaele, M., Beano, A., Franco, A., Valerio, M. R., Verderame, F., Fontana, A., Haspinger, E. R. & Caldara, A. & 4 others, Di Leone, A., Tortora, G., Giannarelli, D. & Scambia, G., 8 Sept 2023, In: NPJ breast cancer. 9, 1, p. 73
Research output: Contribution to journal › Original Article › peer-review

Open Access

Cite this

Fabi, A., Carbognin, L., Botticelli, A., Paris, I., Fuso, P., Savastano, M. C., La Verde, N., Strina, C., Pedersini, R., Guarino, S., Curigliano, G., Criscitiello, C., Raffaele, M., Beano, A., Franco, A., Valerio, M. R., Verderame, F., Fontana, A., Haspinger, E. R., ... Scambia, G. (2024). Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer. NPJ breast cancer, 10(1), 13. https://doi.org/10.1038/s41523-024-00619-5

@article{9ece638b56f74d6494de2a7e6ce17313,

title = "Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer",

author = "Alessandra Fabi and Luisa Carbognin and Andrea Botticelli and Ida Paris and Paola Fuso and Savastano, \{Maria Cristina\} and \{La Verde\}, Nicla and Carla Strina and Rebecca Pedersini and Stefania Guarino and Giuseppe Curigliano and Carmen Criscitiello and Mimma Raffaele and Alessandra Beano and Antonio Franco and Valerio, \{Maria Rosaria\} and Francesco Verderame and Andrea Fontana and Haspinger, \{Eva Regina\} and Alessia Caldara and \{Di Leone\}, Alba and Giampaolo Tortora and Diana Giannarelli and Giovanni Scambia",

note = "nicht zu werten, Korrektur",

year = "2024",

month = feb,

day = "5",

doi = "10.1038/s41523-024-00619-5",

language = "English",

volume = "10",

pages = "13",

journal = "NPJ breast cancer",

issn = "2374-4677",

publisher = "NATURE PORTFOLIO",

number = "1",

}

Fabi, A, Carbognin, L, Botticelli, A, Paris, I, Fuso, P, Savastano, MC, La Verde, N, Strina, C, Pedersini, R, Guarino, S, Curigliano, G, Criscitiello, C, Raffaele, M, Beano, A, Franco, A, Valerio, MR, Verderame, F, Fontana, A, Haspinger, ER, Caldara, A, Di Leone, A, Tortora, G, Giannarelli, D & Scambia, G 2024, 'Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer', NPJ breast cancer, vol. 10, no. 1, pp. 13. https://doi.org/10.1038/s41523-024-00619-5

TY - JOUR

T1 - Author Correction

T2 - Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer

AU - Fabi, Alessandra

AU - Carbognin, Luisa

AU - Botticelli, Andrea

AU - Paris, Ida

AU - Fuso, Paola

AU - Savastano, Maria Cristina

AU - La Verde, Nicla

AU - Strina, Carla

AU - Pedersini, Rebecca

AU - Guarino, Stefania

AU - Curigliano, Giuseppe

AU - Criscitiello, Carmen

AU - Raffaele, Mimma

AU - Beano, Alessandra

AU - Franco, Antonio

AU - Valerio, Maria Rosaria

AU - Verderame, Francesco

AU - Fontana, Andrea

AU - Haspinger, Eva Regina

AU - Caldara, Alessia

AU - Di Leone, Alba

AU - Tortora, Giampaolo

AU - Giannarelli, Diana

AU - Scambia, Giovanni

N1 - nicht zu werten, Korrektur

PY - 2024/2/5

Y1 - 2024/2/5

U2 - 10.1038/s41523-024-00619-5

DO - 10.1038/s41523-024-00619-5

M3 - Correction

C2 - 38316819

SN - 2374-4677

VL - 10

SP - 13

JO - NPJ breast cancer

JF - NPJ breast cancer

IS - 1

ER -